1. Home
  2. IBIO vs USEA Comparison

IBIO vs USEA Comparison

Compare IBIO & USEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IBIO
  • USEA
  • Stock Information
  • Founded
  • IBIO 2008
  • USEA 2004
  • Country
  • IBIO United States
  • USEA Greece
  • Employees
  • IBIO N/A
  • USEA N/A
  • Industry
  • IBIO Biotechnology: Pharmaceutical Preparations
  • USEA Marine Transportation
  • Sector
  • IBIO Health Care
  • USEA Consumer Discretionary
  • Exchange
  • IBIO Nasdaq
  • USEA Nasdaq
  • Market Cap
  • IBIO 11.9M
  • USEA 10.5M
  • IPO Year
  • IBIO N/A
  • USEA N/A
  • Fundamental
  • Price
  • IBIO $0.66
  • USEA $1.57
  • Analyst Decision
  • IBIO Strong Buy
  • USEA
  • Analyst Count
  • IBIO 2
  • USEA 0
  • Target Price
  • IBIO $5.50
  • USEA N/A
  • AVG Volume (30 Days)
  • IBIO 538.2K
  • USEA 23.7K
  • Earning Date
  • IBIO 09-19-2025
  • USEA 08-12-2025
  • Dividend Yield
  • IBIO N/A
  • USEA 2.55%
  • EPS Growth
  • IBIO N/A
  • USEA N/A
  • EPS
  • IBIO N/A
  • USEA N/A
  • Revenue
  • IBIO $375,000.00
  • USEA $42,595,000.00
  • Revenue This Year
  • IBIO $81.33
  • USEA N/A
  • Revenue Next Year
  • IBIO N/A
  • USEA $11.62
  • P/E Ratio
  • IBIO N/A
  • USEA N/A
  • Revenue Growth
  • IBIO 650.00
  • USEA N/A
  • 52 Week Low
  • IBIO $0.64
  • USEA $1.00
  • 52 Week High
  • IBIO $6.89
  • USEA $2.78
  • Technical
  • Relative Strength Index (RSI)
  • IBIO 33.40
  • USEA 53.73
  • Support Level
  • IBIO $0.71
  • USEA $1.56
  • Resistance Level
  • IBIO $0.78
  • USEA $1.61
  • Average True Range (ATR)
  • IBIO 0.03
  • USEA 0.08
  • MACD
  • IBIO -0.00
  • USEA -0.01
  • Stochastic Oscillator
  • IBIO 6.43
  • USEA 67.70

About IBIO iBio Inc.

iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.

About USEA United Maritime Corporation

United Maritime Corp operates as a shipping company currently specializing in the seaborne transportation of dry bulk commodities. It currently operates one LR2 tanker vessel and three Capesize dry bulk vessels, two Kamsarmax dry bulk vessels, and three Panamax dry bulk vessels, with an aggregate cargo-carrying capacity of approximately 1,004,289 dwt.

Share on Social Networks: